LeonaBio, Inc. Other Non-Current Liabilities
LeonaBio, Inc. (LONA) had Other Non-Current Liabilities of $1.03 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-14
- 2026-06-30: Other Liabilities, Noncurrent $1.03M.
- 2026-03-31: Other Liabilities, Noncurrent $1.22M.
- 2025-12-31: Other Liabilities, Noncurrent $1.40M.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2026-06-30 | $1.03M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $1.22M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $1.40M 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |